UConn-Canaan Fellowship Program
Blanka Rogina, Ph.D.
Chair, UConn-Canaan Fellowship Program Committee
The University of Connecticut Schools of Medicine and Dental Medicine and Canaan Partners are proud to offer venture capital and entrepreneurship fellowship opportunities for Ph.D., M.D., M.D./Ph.D., D.M.D., or D.M.D./Ph.D. students. Canaan Partners is a multibillion-dollar venture capital firm focused on investments in early stage health care and technology companies. Fellows work in multidisciplinary teams that provide scientific review, due diligence, and when relevant, business strategy, and market analysis around new ventures and potential investment opportunities. Students selected receive hands-on training through working directly on real life, venture capital projects with Tim Shannon, M.D., general partner (and 1985 alum of the UConn School of Medicine), and Colleen Cuffaro, Ph.D., principal, of Canaan Partners.
Application guidelines for the 2023 UConn-Canaan Fellowship competition will be distributed in the Spring.
Tommy Nelson is a second-year dental student at the University of Connecticut School of Dental Medicine. He grew up in Seattle, WA and earned a bachelor's degree in Microbiology at Brigham Young University. His current research focuses on new applications of Cone-beam computed topography in the dental field. Before dental school, Tommy gained extensive business development experience and sourced over $10m of recurring revenue in his previous employment. He is grateful for the opportunity to now gain first-hand experience in due diligence, business strategy, and scientific review. Tommy is passionate about innovative and disruptive ideas and he hopes to someday leverage these skills to build solutions to patient care distribution and effectively serve a wider patient population.
Anthony Pettinato is in his final year of the UConn MD/PhD Program. He completed his undergraduate degree in Biology at the University of Maryland, after which he was a postbac research fellow at the National Institutes of Health. For his PhD studies, Anthony worked in Dr. Travis Hinson’s lab at the Jackson Laboratory for Genomic Medicine. With funding from the American Heart Association, he developed high-throughput methods for predicting how genetic mutations can lead to different forms of heart failure, and harnessed state-of-the-art genomic technologies to better understand cardiac regeneration. In his spare time, Anthony enjoys spending time with his wife, Feria, and playing with his dog, an Australian Shepherd named Hercules.
Bennett Propp is a third-year medical student at the University of Connecticut School of Medicine. His interest in pursuing a career in medicine was fostered by his studies in Biomedical Engineering and Materials Science Engineering as an undergraduate at the University of Connecticut. Bennett has performed research in designing synthetic cartilage, analyzing the genomics of Type I Diabetes, and evaluating outcomes of surgical techniques for those with chronic knee instability at institutions such as Boston Children’s Hospital and the Hospital for Special Surgery. Bennett is looking forward to partaking in the UConn-Canaan Fellowship Program this summer and learning the skills of device development, business analysis, and biotechnology investment that help bring vital interventions from the benchtop to the place where they can improve lives at a considerable scale.
Max Trudeau is a third year Medical Student at the University of Connecticut. Prior to Medical School, he worked as a Harrison Surgical Scholar at the University of Pennsylvania School of Medicine conducting clinical research for pancreatic surgery. His research focused on progressing surgical risk stratification and prediction of pancreatic fistula, as well as evaluating the efficacy of intraoperative mitigation strategies. The past two years, he worked as the lead developer producing a smartphone application and website entitled FRS Risk that provides real-time patient risk assessment for pancreatic surgery, and automatically calculates surgeon outcome performance metrics. Additionally, Max has also been involved in clinical and biomechanical orthopaedic research at the Musculoskeletal Institute under Dr. Augustus Mazzocca. Max currently serves as a board member of the Research Interest Group at the University of Connecticut School of Medicine. Max is hoping to pursue an academic surgical career and leverage this experience to innovate in the future improving surgical care and efficiency.
Charlotte Winkler is a third year medical student whose interest in the business side of medicine was piqued during her time at Yale University where she worked with one of her professors on the process of launching a new platform based biotechnology company. She was involved in all aspects of the process from drug efficacy studies for the cancer therapeutic, to marketing materials for potential investors, to next steps for IND approval. She is interested in everything from surgery to family medicine, and is also excited to learn about alterative career options where medical knowledge is an asset. She is a cyclist and trail runner, and enjoys competing in long distance events.
Pengyu Zong is a third-year Biomedical PhD student at UConn Health studying the prevention and treatment of ischemic stroke. He grow in Jiangsu, China and earned his M.D. degree at Xuzhou Medical University in 2016. After finishing his residency at Nanjing Medical University in 2019, he came to U.S. to pursue a Ph.D. degree with the concentration of Cardiology and Neuroscience. His research mainly focus on screening serum biomarkers for predicting the risk of ischemic stroke and developing more effective therapies for mitigating the brain injury during ischemic stroke. He has already identified a promising small peptide that can effectively attenuate ischemic stroke in model mice and applied a provisional patent for this discovery. Several pharmaceutical companies have shown interest in his patent. He wishes to apply his novel therapy into clinical trials to save more patients with ischemic stroke. He appreciates the Canaan Fellowship Program for giving him the valuable entrepreneurial experience, and for preparing him for building his own biocompany in the future. In his spare time he enjoys hiking, fishing and hunting with friends.
About Canaan Partners
Tim Shannon, M.D.
Dr. Shannon pairs his operating experience and medical background to create value for companies from the earliest stage through FDA approval. Prior to becoming an investor, Tim was president and chief executive officer of CuraGen, a publicly traded biopharmaceutical company focused on oncology. He began his career as a pulmonary and critical care physician. Tim earned his medical degree from the University of Connecticut in 1985 and has a B.A. in chemistry from Amherst College.
Colleen Cuffaro, Ph.D.
Dr. Cuffaro's investment focus is early stage biopharmaceutical companies. Her interests lie in transformative medical technologies that deliver value to providers and patients alike. In her time at Canaan, Colleen helped launch the Canaan-Yale Fellowship program. Colleen previously worked as a chemist at Pharmaceutical Manufacturing and Research Services, Inc. She holds a Ph.D. in Cellular and Molecular Physiology from Yale University and a B.A. in Chemistry from the University of Pennsylvania.
Sergio Acevedo Cortes is a second-year dental student at the University of Connecticut School of Dental Medicine. He grew up in Moca, Puerto Rico and earned a bachelor's degree in Biology with a concentration in Biomedical Sciences from the University of Puerto Rico in Aguadilla. An avid investor since the age of 16, partaking in the Canaan Fellowship program allowed him to combine his interest in finance with his passion for healthcare. Increasing his knowledge on how venture capital assists in the development of clinical innovations in the realm of dental medicine and beyond.
Ryan Beach is a fourth year PhD student at UConn Health studying Molecular Oncology. He received his BS in Allied Health Sciences and MS in Applied Genomics from UConn Storrs. After completing his M.S., Ryan worked at small Biotech startup for two years developing next generation microbiome sequencing assays for clinical and basic research. His research focuses on studying the effect of natural and synthetic compounds on Colorectal Cancer prevention. Upon graduation he wishes to pursue a career in biotech with a focus on brining cancer therapies to market. In his spare time, he enjoys spending time with his wife and son and hiking with friends.
Dea Gorka is a fifth year Biomedical Ph.D. student at UConn Health. She was born in Tirana, Albania and came to the United States with her family in 2000. She earned her B.S. from the University of Connecticut-Storrs, where she majored in Physiology and Neurobiology with a minor in Psychology. Her doctoral research focuses on using patient-specific induced pluripotent stem cells to better understand genetic and cellular deficits underlying two 15q imprinting disorders: Angelman syndrome (AS) and Prader-Willi syndrome (PWS). Her overall goal is to gain a broader understanding of how imprinted expression of the 15q region is epigenetically regulated in human stem cells and neurons, with the long-term goal of expediting the development of potential therapeutics for AS and PWS. She is grateful for the experience at the Canaan Fellowship Program for giving her first-hand experience on venture capital projects, and for increasing her knowledge about investing in the biopharmaceutical industry. In her spare time she enjoys hiking, playing tennis and soccer, traveling, and spending time with her cat Cashew.
Ziwei Pan is a Ph.D. student in the Biomedical Sciences program at UConn Health, currently conducting the dissertation research in Sheng Li’s lab at the Jackson Laboratory for Genomic Medicine. Her work is focused on developing computational framework on third-generation sequencing for epigenome study. She is grateful to the Canaan Fellowship Program for providing her with the professional venture capital knowledge and perspectives, and helping her turn the nascent interest in the healthcare business into real-world biotech investing project experience. Ziwei is a fan of literature and music, and she enjoys playing with her rescue dog named Gemma.
Benjamin Pesante is a current second year Medical Student at the University of Connecticut. Prior to medical school, he worked as a remediation engineer for Cardinal Health, a large health care supply company. While working to ensure medical devices conformed with company, national, and international regulations and specifications, Benjamin learned about the intricacies product development and remediation. He is interested in continuing to learn about the business of health care to become a better physician in the future and create meaningful change through innovation. Benjamin is interested in many medical specialties, including neurosurgery, emergency medicine, and family medicine, and in his free time enjoys working out and spending time with family.
Adam Thiesen is entering the second year of the MD/PhD program at UConn School of Medicine. He is interested in immunology and oncology, and has worked in labs at the Fred Hutchinson Research Center and Mass General Hospital. Adam is also the founder of the healthcare app ScrubsOnly (which can be find online or on the iOS app store). When he is not studying or working, you can find him playing pickup basketball with classmates at Stanley Quarter Park in New Britain.
Laura Doherty is 7th year DMD/PhD student. She successfully defended her PhD dissertation and is in the final two years of dental school. She grew up in Harrison, NY and earned a B.A. from the University of Pennsylvania, where she double majored in biology and religious studies. Her doctoral research focuses on skeletal stem cells and their role in bone regeneration, and she intends to pursue a career in research and academia. Laura is a licensed pilot with an additional rating for seaplanes, and enjoys spending time with her dog, a Nova Scotia duck tolling retriever named Murray.
Kyle Grabowski is a second-year student at the University of Connecticut School of Dental Medicine from Monroe, CT. Kyle currently serves in the American Dental Student Association District 1 Cabinet as a Professional Development Committee Vice-Chair, and is heavily involved on other student dental societies on campus. As an undergraduate at the University of Pittsburgh, he was exposed to research as an assistant in a lab studying influenza and served as the president of the Pitt Dental Science Club and the Pittsburgh Ski and Snowboard Club. He hopes to gain new perspectives on the wide-reaching applications of research and use this introduction of the field of venture capital investing to view research projects from a new lens.
Vijay Kodumudi is a 4th year medical student at UConn School of Medicine. He grew up in Fairfield, CT before attending the University of Connecticut in Storrs, CT, where he earned his B.S. in Molecular Cell Biology with a minor in Sociology. During his time in college and medical school, he interned in multiple biotech startups, where his responsibilities included market research, patent registration, and coordination of clinical trials. Vijay completed his MBA degree at the UConn Graduate School of Business as part of a dual degree M.D./M.B.A. program. In his spare time, he likes playing basketball, hiking, and listening to music.
Peter Larson is an MD/PhD Student at UConn School of Medicine, currently finishing his dissertation research in Julia Oh’s group at the Jackson Laboratory for Genomic Medicine. Peter completed his undergraduate degrees in Pathobiology and Molecular & Cell Biology from the University of Connecticut in 2015. He is the recipient of the Barry Goldwater Scholarship for his previous work engineering complex genetic circuits in viral vectors for vaccines and oncolytic viral therapies. His graduate work seeks to characterize the relationship between aging, the microbiome, and infection risk, as well as to engineer skin probiotics that can deliver nanobody therapeutics or even detect and kill pathogens such as Methicillin Resistant Staphylococcus aureus (MRSA).
Socheata Lim earned a B.A. in Chemistry from Western Connecticut State University. She went on to become a researcher at Duracell working to improve the technology in alkaline batteries. Currently, she is a Ph.D. student in Biomedical Science at UConn Health and is interested in drug discovery. Her thesis is focused on using NMR spectroscopy and biophysical techniques to study the interactions and dynamics of the E. coli β-clamp, which is a druggable target for new antibiotics. She also took a biomedical entrepreneurship course through the UConn School of Business where she learned the inner workings of how to create a biotech start-up, including how to develop business plans to pitch to investors. She is grateful for the experience at the Canaan Fellowship Program for giving her first-hand experience on venture capital projects, and for increasing her knowledge about investing in the biopharmaceutical industry. In her spare time, she enjoys playing tennis and playing with her dog, Duke.
Anthony Sposato is a rising second year medical student who spent time before medical school working in academia and the biotech industry as a researcher. He has worked towards bringing molecular technologies to market and has published a paper on the inheritance of dicentric chromosomes—a unique type of chromosome involved in various types of cancers—in fruit flies. In his free time, he enjoys literature, travel, and skateboarding.
Omar Allam is a medical student at UConn School of Medicine. He attended UConn where he received his B.S. in Chemistry, summa cum laude. He received the American Chemical Society award and recognition as a University Scholar for his outstanding work in chemistry and research. Omar has always had a passion for business through the years he has been a part DECA, a fellow for How I Built This/NPR, and has led and been involved in various local startups. Omar plans to pursue surgery.
Christian Ayeni is a rising second year dental student with a background in virology and bioengineering and a general interest in business. During his undergraduate years, he was an active member of his college's Business Club, and as a graduate student, he was a fellow with the Office of Technology Development at Harvard. He joined the UConn-Canaan Fellowship to learn more about the behind-the-scenes details regarding what makes ideas and businesses successful and the steps necessary to secure funding from venture capital groups. As a fellow, he has learned about the many steps of due diligence that go into selecting startup companies in which to invest.
Menghan Du is a Ph.D. student in the Biomedical Sciences program at UConn Health. Her research is focused on developing CRISPR-based strategies for cell engineering and disease treatment. Before attending graduate school, she worked in a Chinese startup company for IVD device, where she began to be interested in working for a multidisciplinary team of life science. As an enthusiast of cutting-edge biotechnology, she hopes to provide her scientific ideas to biotech companies after graduation. Menghan appreciates this opportunity given by the UConn-Canaan Fellowship to learn about venture capital in the biotech field.
Ryan Englander is a second year M.D./Ph.D. student at the University of Connecticut. He is working to leverage the exciting new CRISPR-based gene editing technologies to develop genetic therapies that target tumors on a patient-specific basis. When he is not in class or the lab, he enjoys traveling, hiking, skiing, swimming, and playing with his cat.
Shaan Kamal is a medical student at the UConn School of Medicine. He also attended UConn for his undergraduate studies and earned his B.S. in Molecular and Cellular Biology and his M.S. in Structural Biology, Biochemistry, and Biophysics while doing research in computational biology. His interests lie at the intersection between health care, academia, and business with particular interests in computational psychiatry and digital health.
During the 2019 fellowship Britt Knight was finishing her dissertation in the Biomedical Sciences Ph.D. program at UConn Health. Her research focused on understanding the relationship between key molecules involved in wound healing and the normal progression of pain during inflammatory conditions. After completing her doctoral work, she continued research as a postdoctoral fellow funded by the T90 NIDCR training grant in the Connecticut Convergence Institute. Under the supervision of Dr. Lakshmi Nair Dr. Knight established new animal models for formulating biomaterial drug delivery systems for treating musculoskeletal pain. Currently Dr. Knight works for the United States Association for the Study of Pain as a program coordinator and is the Director of the Connecticut Junior Science and Humanities Symposium (JSHS).
Scott Adamson is currently a Ph.D. student in the Biomedical Sciences program at UConn Health in the Graveley lab. His research focuses on developing and utilizing high-throughput reporter assays in order to study how genetic variants can impact pre-mRNA splicing. Scott also studies the diverse functions of many RNA-binding proteins and how they can impact the transcriptome. He is interested in exploring different career opportunities for employment after graduation and is grateful for the opportunity from the UConn-Canaan Fellowship to learn about venture capital in the biotechnology industry. He received his B.S. in Environmental Science from the University of Connecticut.
Mitali Adlakha received her Ph.D. in Molecular Biology and Biochemistry from UConn Health in 2019. Mitali has been working in life sciences consulting since she graduated. She is currently associate consultant at IQVIA consulting services. In this position, she executes a variety of strategy and commercial implementation projects in life science and pharma space, consulting for most big biopharma clients. Her projects revolve around reimbursement, pricing, market access, forecasting/ asset valuation and product/portfolio strategy in US, EU5 and Asia. Mitali is extremely grateful to the Canaan Fellowship Program for providing exposure to the business side of healthcare. The knowledge gained from the fellowship is applicable to real world projects in consulting and was a great help during job interviews.
Christian Gronbeck is a medical student at UConn School of Medicine in the class of 2021. He originally grew up in Simsbury, CT before later attending Williams College in MA, where he received his B.A. in Chemistry and Economics and was a member of the varsity swim team. Before attending medical school, Christian was a healthcare consultant at ClearView Healthcare Partners in Boston, MA. Here, he was involved in performing market research on various disease states in order to develop strategic business plans for novel therapeutics and diagnostic devices. In his spare time, he enjoys staying active and recently completed an Ironman Triathlon in 2017.
Gerard J. Kerins was born and raised in Madison, CT before graduating from the College of the Holy Cross with a bachelor’s degree in chemistry in 2014. He subsequently enrolled in the UConn School of Medicine, having just completed his third year. Gerard completed his MBA degree at the UConn Graduate School of Business as part of a dual degree M.D./M.B.A. program. He has business and entrepreneurial aspirations in medicine, and is likely to pursue a career in anesthesiology. He is the oldest of five and enjoys pickup basketball, fantasy football, and horror films.
Patrick McMullan earned his B.S. in Biomedical Sciences from the Rochester Institute of Technology, and also holds over 5 years of industry experience with early staged biotechnology and medical device companies. Through his full-time roles as well as consulting, Patrick has successfully filed both IND and IDE applications with the FDA, and has played a direct role in launching clinical trials in the United States and internationally. Patrick is currently an M.D./Ph.D. student at the University of Connecticut and holds an interest in exploring the translational applications of Skeletal Biology and Regenerative Medicine into clinical practice.